What is the Impact Factor of Seminars in Arthritis and Rheumatism?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Seminars in Arthritis and Rheumatism is 3.80, ranking in quartile Q2 of Web of Science (SCIE).

Is Seminars in Arthritis and Rheumatism indexed in Web of Science or Scopus?

Yes, Seminars in Arthritis and Rheumatism is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.454 (Q1) and an H-index of 147.

Who publishes Seminars in Arthritis and Rheumatism and what is the Article Processing Charge (APC)?

Seminars in Arthritis and Rheumatism is published by W.B. Saunders Ltd. The estimated Article Processing Charge (APC) is approximately $3,640 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Seminars in Arthritis and Rheumatism?

The official ISO-4 abbreviation of Seminars in Arthritis and Rheumatism is "SEMIN ARTHRITIS RHEU" with common acronym "ysarh". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q1SCImago #2,567Top JournalHybrid

Seminars in Arthritis and Rheumatism

Acronym:ysarh

•

Abbreviation (ISO):SEMIN ARTHRITIS RHEU

•

Identifier (ISSN):0049-0172(Print)/1532-866X(Online)

•

Publisher:W.B. Saunders Ltd

Official Website Submission Portal Compare

Clarivate IF (2026)

3.8↓ -0.6

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Seminars in Arthritis and Rheumatism

WoS Q2

Annual Impact Factor Metric

Current (2026):3.8

Scopus SJR & RankScopus Q1

1.454

#2,567

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

147

147 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate4.3%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

152articles/year

38.29% Gold OA•76.74% Original Research

Aims & Scope

Seminars in Arthritis and Rheumatism provides access to the highest-quality clinical, therapeutic and translational research about arthritis, rheumatology and musculoskeletal disorders that affect the joints and connective tissue. Each bimonthly issue includes articles giving you the latest diagnostic criteria, consensus statements, systematic reviews and meta-analyses as well as clinical and translational research studies. Read this journal for the latest groundbreaking research and to gain insights from scientists and clinicians on the management and treatment of musculoskeletal and autoimmune rheumatologic diseases. The journal is of interest to rheumatologists, orthopedic surgeons, internal medicine physicians, immunologists and specialists in bone and mineral metabolism.

Topics Covered (Recognized by AI)

Medicine99.8%Internal medicine81.2%Biology79.4%Pathology72.6%Immunology56.6%Surgery45.2%Disease40.1%Genetics36.6%Psychology30.3%Chemistry29.3%Rheumatoid arthritis28.6%Psychiatry26.1%Biochemistry26%Dermatology25.3%Radiology24.4%Mathematics24.1%Arthritis22.8%Endocrinology21.7%Statistics20.1%

Primary Research Areas

Medicine Rheumatology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

RHEUMATOLOGY

Rank15/58

IndexSCIE

JCISCIE2026

RHEUMATOLOGY

Rank12/58

IndexSCIE

Category	Index	Rank	Quartile
RHEUMATOLOGY	JCRSCIE	15/58	Q2
RHEUMATOLOGY	JCISCIE	12/58	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.8

Articles / Year170

Total Citations49

2025

IF4.4

Articles / Year273

Total Citations764

2024

IF4.6

Articles / Year231

Total Citations1,521

2023

IF5

Articles / Year185

Total Citations1,991

2022

IF5.431

Articles / Year199

Total Citations3,519

Year	Impact Factor	Articles / Year	Total Citations
2026	3.8	170	49
2025	4.4	273	764
2024	4.6	231	1,521
2023	5	185	1,991
2022	5.431	199	3,519
2021	5.532	173	3,840
2020	4.751	218	7,850
2019	5.072	143	5,644
2018	4.356	157	7,223
2017	—	165	7,272
2016	—	140	8,888
2015	—	143	8,031

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,567Scopus Q1SCImago Profile

Scopus Coverage:1971-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q1

1.454

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

3.47

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,640 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,209

3-Year Documents598

Citable Documents518

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate49.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Anesthesiology and Pain MedicineQ1

RheumatologyQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 4.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

2区RHEUMATOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Seminars in Arthritis and Rheumatism (acronym: ysarh, abbr: SEMIN ARTHRITIS RHEU, ISSN: 0049-0172) is a peer-reviewed international scholarly journal in the field of Medicine, published by W.B. Saunders Ltd in United States since 1971. The periodical holds a Journal Impact Factor (JIF) of 3.80, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.454 (Q1), an H-index of 147.

The journal enforces rigorous peer evaluation with an average review speed of 8.2周, a publication frequency of Bimonthly, an annual output of approximately 152 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,640 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.